Lisa Wyman

Mimecast Microsoft Office 365 Adobe Marketing Cloud WordPress.org Google Analytics New Relic reCAPTCHA Google Tag Manager Mobile Friendly Typekit Lever Vimeo Google Font API Render Remote

biotechnology: biological products (no diagnostic substances) health care biopharmaceutical drug discovery spinal muscular atrophy oncology anemia fibrosis clinical trials growth factors protein structures biologics monoclonal antibodies therapeutic solutions patient-centered care disease modification growth factor-targeted therapies neuromuscular disease transforming growth factor tgf signaling pro-fibrotic signaling metabolic regulation iron metabolism therapeutic innovation science-based approach pipeline development preclinical studies clinical efficacy emerging treatments collaboration research partnerships investor relations medical advancement broad application life-changing therapies unmet medical needs protein modulation healthcare outcomes regenerative medicine selectivity in drug action preclinical data protein co-receptors clinical insights patients & families healthcare innovation scientific research disease-targeted therapies advancing standard of care innovative therapies serious diseases sma muscle-targeted treatment apitegromab neuromuscular disorders cardiometabolic disorders obesity myostatin inhibitor srk-439 patient-centered approach transformative therapies healthcare pharmaceutical industry latent growth factors disease biology novel monoclonal antibodies tgfβ superfamily patient demographics healthcare professionals clinical proof-of-concept metabolic disorders cancer treatments proprietary platform therapeutic strategies health wellness & fitness hospital & health care